AZD5423
AZD5423 is a nonsteroidal glucocorticoid and phase II drug by AstraZeneca disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat respiratory diseases and in particular chronic obstructive pulmonary disease.
primaryTopic
AZD5423
AZD5423 is a nonsteroidal glucocorticoid and phase II drug by AstraZeneca disclosed at the spring 2013 American Chemical Society meeting in New Orleans to treat respiratory diseases and in particular chronic obstructive pulmonary disease.
has abstract
AZD5423 is a nonsteroidal gluc ...... obstructive pulmonary disease.
@en
IUPAC name
2,2,2-Trifluoro-N-[(1R,2S)-1-{ ...... xyphenyl)-2-propanyl]acetamide
@en
thumbnail
Wikipage page ID
39,105,397
Wikipage revision ID
713,194,777
ChemSpiderID
28,536,140
molecular weight
4.87446e+2
smiles
StdInChIKey
FCNQMDSJHADDFT-WNSKOXEYSA-N
hypernym
comment
AZD5423 is a nonsteroidal gluc ...... obstructive pulmonary disease.
@en
label
AZD5423
@en
